Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
15.44 AUD | +0.32% | +2.52% | -3.50% |
29/04 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
14/03 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.50% | 498M | |
-2.52% | 88.14B | |
+3.29% | 40.44B | |
-15.40% | 32.24B | |
+51.96% | 24.39B | |
-14.35% | 15.59B | |
-39.65% | 12.3B | |
-6.52% | 12.18B | |
-13.41% | 12.14B | |
+5.17% | 8.87B |
- Stock Market
- Equities
- CUV Stock
- News Clinuvel Pharmaceuticals Limited
- Clinuvel Pharmaceuticals Treats First Patient in Phase Two Stroke Trial